Chongxi Song has extensive experience in business development, particularly in the field of therapeutic antibody discovery/CMC/CDMO service. From September 2015 to December 2016, they worked as a BD Manager at Nanjing GenScript Biotech Corporation. In this role, they were responsible for business development in Zhangjiang Hi-Tech Park. From January 2017 to February 2020, they continued to work as a BD Manager at GenScript ProBio, focusing on business development in Shanghai. In both positions, their responsibilities included promoting and expanding the company's therapeutic antibody discovery/CMC/CDMO service.
Chongxi Song completed their Bachelor's degree in Biological Science at Anhui Normal University from 2008 to 2012. Following this, they pursued further education and obtained a Master's degree in Biology from Soochow University in China from 2012 to 2015.